N1-(3,4-Dihydroxyphenethyl)-N6-phenethyladipamide is an intermediate of Dopexamine (D533900), which is a synthetic dopamine analog and acts as a a β2-adrenergic receptor agonistt as well as an agonist at peripheral dopamine receptors. Dopexamine has been used to improve myocardial and renal performance in patients suffering from low cardiac output states.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.